Results 141 to 150 of about 164,741 (262)

Cognitive mapping: Enhancing discussions in the transdisciplinary design and health research space? [PDF]

Des J (Aldershot)
Macdonald AS.
europepmc   +1 more source

Path Integration and Cognitive Mapping Capacities in Down and Williams Syndromes. [PDF]

Front Psychol, 2020
Bostelmann M, Ruggeri P, Rita Circelli A, Costanzo F, Menghini D, Vicari S, Lavenex P, Banta Lavenex P.   +7 more
europepmc   +1 more source

Increased Hippocampal Excitability and Altered Learning Dynamics Mediate Cognitive Mapping Deficits in Human Aging. [PDF]

J Neurosci, 2021
Diersch N, Valdes-Herrera JP, Tempelmann C, Wolbers T.   +3 more
europepmc   +1 more source

Evaluation of Digital Technologies for Home‐Based Assessment in People With Amyotrophic Lateral Sclerosis

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Digital technologies hold promise for transforming healthcare by enhancing personalized treatments and offer valuable opportunities to improve patient care. Here, we evaluated several novel, self‐administered, home‐based, digital endpoints for their association with corresponding conventional standard clinical measures (primary) in ...
Arne Mueller, Vanessa Vallejo, Mónica Povedano Panadés, Orla Hardiman, Véronique Danel‐Brunaud, Senda Ajroud‐Driss, Philippe Couratier, Jeremy Shefner, Anna Gokey, Mike DiCesare, Erin Lennox, Jens Praestgaard, Lucie Brujin, Peggy Allred, Ram Miller   +14 more
wiley   +1 more source

Socio-cognitive constraints and opportunities for sustainable intensification in South Asia: insights from fuzzy cognitive mapping in coastal Bangladesh. [PDF]

Environ Dev Sustain, 2021
Aravindakshan S, Krupnik TJ, Shahrin S, Tittonell P, Siddique KHM, Ditzler L, Groot JCJ.   +6 more
europepmc   +1 more source

Unraveling 4‐Phenylbutyrate's Therapeutic Role in SLC6A1 Disorders: Pharmacochaperoning Over HDAC Inhibition

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Variants in SLC6A1, encoding the GABA transporter 1 (GAT‐1), cause epilepsy, autism spectrum disorder, and developmental delay via loss of GABA uptake, impaired trafficking, and ER retention. We previously found that 4‐Phenylbutyrate (PBA), an FDA‐approved drug, restores GABA uptake and reduces seizures in SLC6A1‐related disorders ...
Melissa B. DeLeeuw, Karishma Randhave, Ekta Anand, Ziang (Debbie) Song, Wangzhen Shen, Jing‐Qiong Kang   +5 more
wiley   +1 more source

Exploring Determinants of Compassionate Cancer Care in Older Adults Using Fuzzy Cognitive Mapping. [PDF]

Curr Oncol
Tremblay D, Russo C, Terret C, Prady C, Joannette S, Lessard S, Usher S, Pretet-Flamand É, Galvez C, Gélinas-Phaneuf É, Terrier J, Moreau N.   +11 more
europepmc   +1 more source

Supporting Underrepresented Students in Health Sciences: Using a Fuzzy Cognitive Mapping Approach

, 2023
Chiang DF, Guerrero SA, Sexton EC.
europepmc   +1 more source

Video data for the cognitive mapping process of NeuroBayesSLAM system. [PDF]

Data Brief, 2020
Zeng T, Si B.
europepmc   +1 more source

Sex‐Stratified Association of Regional Dopamine Transporter Binding With Disease Progression in Amyotrophic Lateral Sclerosis

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective To clarify the clinical relevance of dopamine transporter single‐photon emission computed tomography (DAT‐SPECT) abnormalities in amyotrophic lateral sclerosis (ALS), with a prespecified focus on sex‐stratified associations with disease progression and short‐term prognosis.
Tomoya Kawazoe, Keizo Sugaya, Kentaro Hayashi, Keiko Hino, Yasuhiro Nakata, Kota Bokuda, Toshio Shimizu, Kazushi Takahashi   +7 more
wiley   +1 more source